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Cabin 1, A Negative Regulator
for Calcineurin Signaling in T Lymphocytes
Calcineurin is known to modulate the activity of sev-
eral transcription factors that bind to the IL-2 promoter,
including NF-AT, NF-kB, and AP-1 (Emmel et al., 1989;
Luo Sun,* Hong-Duk Youn,* Christine Loh,*§
Melissa Stolow,² Weiwu He,² and Jun O. Liu*³
*Center for Cancer Research
and Departments of Biology and Chemistry Frantz et al., 1994; Su et al., 1994). Among these tran-
scription factors, calcineurin has been shown to dephos-Massachusetts Institute of Technology
Cambridge, Massachusetts 02139 phorylate the cytoplasmic subunit of NF-AT, allowing it
to translocate into the nucleus to activate transcription²OriGene Technologies Incorporated
Rockville, Maryland 20850 (Flanagan et al., 1991; Shaw et al., 1995; Loh et al., 1996;
Timmerman et al., 1996). Recent studies have shown
that activated calcineurin comigrates with the cyto-
plasmic subunit of NF-AT into the nucleus, where it maySummary
be required in sustaining the activation of NF-AT (Shiba-
saki et al., 1996). In addition to the cytoplasmic subunitCalcineurin plays a pivotal role in the T cell receptor
of NF-AT, calcineurin has been shown to dephosphory-(TCR)±mediated signal transductionpathway and serves
late the transcription factor Elk-1, down-regulating itsas a common target for the immunosuppressants FK506
transcriptional activity (Sugimoto et al., 1997). Cal-and cyclosporin A. We report the identification of a
cineurin has also been reported to bind several othernovel endogenous calcineurin binding protein named
cellular proteins, including the protein kinase A anchor-Cabin 1 that inhibits calcineurin-mediated signal trans-
ing protein (AKAP79) (Coghlan et al., 1995; Klauck et al.,duction. The interaction between Cabin 1 and cal-
1996) and the IP3 and ryanodine receptors (Cameron etcineurin is dependent on PKC activation. Overexpres-
al., 1995). To what extent these calcineurin-associatedsion of Cabin 1 or its N-terminal truncation mutants
proteins are involved in TCR signaling remains to beinhibits the transcriptional activation of calcineurin-
determined.responsive elements in the interleukin-2 promoter and
Calcineurin belongs to a superfamily of protein serine/blocks dephosphorylation of NF-AT upon T cell activa-
threonine phosphatases (Klee et al., 1988; Cohen, 1989;tion. These results suggest a negative regulatory role
Shenolikar, 1994). Unlike other members of this super-for Cabin 1 in calcineurin signaling and provide a pos-
family, however, the activity of calcineurin is controlledsible mechanism of feedback inhibition of TCR signal-
by intracellular calcium concentrations. This is madeing through cross-talk between protein kinases and
possible by the unique structure of the enzyme. Cal-calcineurin.
cineurin consists of two subunits, a catalytic subunit (A)
and a regulatory subunit (B). The A subunit contains
several distinct structural domains, including a catalyticIntroduction
domain, a B subunit binding domain, a calmodulin bind-
ing domain, and an autoinhibitory domain (Figure 1A).Calcineurin (also known as PP-2B), a calcium and
The calmodulin binding domain and the autoinhibitorycalmodulin-dependent protein serine/threonine phos-
domain together form the calcium-sensing on±off switch.phatase, is a rate-limiting enzyme in T cell receptor
At low calcium concentrations in quiescent T cells, the(TCR)±mediated signal transduction leading to the tran-
autoinhibitory domain of calcineurin binds to the cata-scriptional activation of cytokines such as IL-2 (Crabtree
lytic domain, keeping calcineurin inactive (Hashimotoand Clipstone, 1994). The role of calcineurin in TCR
et al., 1990). During T cell activation, the increase insignaling was first revealed when it was identified as
intracellular calcium concentration leads to activation ofthe common target for the immunosuppressive drugs
calmodulin, which interacts with the calmodulin bindingcyclosporin A (CsA) and FK506 (Friedman and Weiss-
domain of calcineurin A, releasing the autoinhibitory do-man, 1991; Liu et al., 1991). Upon entering T cells, CsA
binds to cyclophilin (Handschumacher et al., 1984), and main of calcineurin from its active site and activating its
FK506 binds to FKBP (Harding et al., 1989; Siekierka et phosphatase activity. Proteolytic removal of the autoin-
al., 1989). The cyclophilin±CsA and FKBP±FK506 com- hibitory domain and a point mutation within the autoin-
plexes independently associate with calcineurin and in- hibitory domain have been shown to give rise to a consti-
hibit its protein phosphatase activity (Friedman and tutively active form of calcineurin (Hubbard and Klee,
Weissman, 1991; Liu et al., 1991). Substantialpharmaco- 1989; Fruman et al., 1995).
logical and cell biological evidence now exists support- Although much is known about how calcineurin is
ing an essential role of calcineurin in the TCR signal activated, little is known about how it is down-regulated
transduction pathway (Clipstone and Crabtree, 1992; following T cell activation. We report herein the identifi-
Fruman et al., 1992; Liu et al., 1992; O'Keefe et al., 1992; cation of a novel calcineurin binding protein named
Nelson et al., 1993). Cabin 1, which binds to and inhibits the phosphatase
activity of calcineurin. The interaction between Cabin 1
and calcineurin is dependent on both PKC and calcium³To whom correspondence should be addressed (e-mail: junliu@
signals. We show that Cabin 1 is a phosphoprotein,mit.edu).
and PKC activation leads to its hyperphosphorylation.§Present address: ICOS Corporation, 22021 20th Avenue S.E.,
Bothell, WA 98021. Expression of Cabin 1 or its C-terminal fragments blocks
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Figure 1. Yeast Two-Hybrid Screen for Cal-
cineurin-Interacting Proteins
(A) Schematic diagrams of wild-type cal-
cineurin and the H160N mutant used as bait.
Abbreviations: CN, calcineurin; CatD, cata-
lytic domain; BBD, CNB binding domain;
CaMBD, calmodulin binding domain; AID,au-
toinhibitory domain. Arrows indicate the sites
of mutation and truncation, respectively, in
the calcineurin bait.
(B) Sensitivity of interaction between Gal4-
DCNb2(H160N) and Cabin 1-14 (see Figures
1D and 2A) to FK506 and CsA. The data for
the remaining three cabin clones are similar
to that for Cabin 1-14.
(C) Sensitivity of interaction between Gal4-
DCNb2(H160N) and Cabin 1-14 to FK506 is
dependent on the presence of endogenous
FKBP12. The concentrations of FK506 and
CsA used were 100 nM and 1 mM, respec-
tively.
(D) Schematic representation of overlapping
clones of Cabin 1 identified from the yeast
two-hybrid screen. All four clones end with
the stop codon of the full-length cDNA (see
Figure 2A).
transcriptional activation of an IL-2 reporter gene in re- (Jiang et al., 1997). When expressed in T cells, this mu-
tant was found to be dominant negative, blocking PMA-sponse to PMA and ionomycin and inhibits the dephos-
and ionomycin-stimulated IL-2 promoter activation byphorylation of NF-AT in vivo. Cabin 1 may thus serve
over 60% (data not shown), in agreement with the previ-as an endogenous inhibitor for calcineurin and play a
ous finding that expression of a similar mutant (H160Q)negative regulatory role in calcineurin signaling.
inhibited nuclear translocation of NF-AT4 (Shibasaki et
al., 1996), a known calcineurin substrate (Jain et al.,
Results 1993; Wesselborg et al., 1996; Beals et al., 1997). We
therefore chose the H160N mutant of the b2 isoform of
Identification of Cabin 1 as a Calcineurin Binding calcineurin as the bait in the yeast two-hybrid system
Protein by Yeast Two-Hybrid Screen (Fields and Song, 1989; Durfee et al., 1993) to identify
To identify new calcineurin substrates and interacting its substrates and binding proteins. To alleviate the de-
proteins, we employed a catalytically inactive calci- pendence of full-length calcineurin on calcium in yeast,
neurin mutant as an affinity probe, reasoning that it the C-terminal autoinhibitory domain and most of the
would associate with substrates more stably than the calmodulin binding domain wereremoved from thecata-
wild-type enzyme, as has been demonstrated for protein lytic subunit in the calcineurin bait (Figure 1A). To vali-
tyrosine phosphatases (Sun et al., 1993; Furukawa, date this strategy, we constructed a fish plasmid encod-
1995). Through site-directed mutagenesis of residues ing a fusion protein between the N-terminal domain of
at the putative active site of calcineurin, we previously NF-AT1 and the Gal4 activation domain and tested
found a number of mutants that are catalytically inactive whether the fusion protein interacted with the cal-
but retain structural integrity as judged by their interac- cineurin bait in the two-hybrid system. Significant acti-
tions with the FKBP±FK506 complex (Mondragon et al., vation of the lacZ reporter gene was observed in yeast
1997). We created a H160N mutant of the b2 isoform of expressing the calcineurin bait and NF-AT fish fusion
proteins (data not shown), indicating that the use of thecalcineurin, the predominant isoform in T lymphocytes
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Figure 2. Amino Acid Sequence and Tissue and Subcellular Distribution of Cabin 1
(A) Amino acid sequence of the putative full-length Cabin 1. Highlighted are a putative coiled-coil domain (bold); putative nuclear localization
sequences (boxed and shaded); PEST sequences (underlined); and a putative SH3 binding site (boxed). The N termini of the four Cabin 1
clones isolated by the yeast two-hybrid screen are highlighted.
(B) Cabin 1 is a nuclear protein. JurkatT cell lysates are fractionated into cytostolic (C) and nuclear (N) fractions,and Cabin 1 was immunoprecipi-
tated using anti±Cabin 1 antibodies. After SDS-PAGE, the immunoprecipitated Cabin 1 was blotted onto a nitrocellulose membrane and probed
with anti±Cabin 1 antibodies or control serum.
(C) Northern blot showing Cabin 1 mRNA is widely expressed in different tissues.
catalytically inactive mutant of calcineurin maybe fruitful Cabin 1 Is a Novel Nuclear Protein with Multiple
for identifying substrates and interacting proteins. Structural Motifs
Upon screening 1.6 million independent transformants Using a combination of EST database searching and
from a mouse T cell cDNA library (Elledge et al., 1991), PCR cloning, the full-length human Cabin 1 was cloned
we identified six clones that exhibited significant activa- to give a complete open reading frame encoding 2220
tion of the lacZ reportergene. To determine the specific- amino acids (Figure 2A). A database search revealed
ity of these clones for calcineurin, we performed the that Cabin 1 is a novel protein. Amino acid analysis of
yeast two-hybrid assay in the presence of FK506 and the conceptually translated sequence revealed a leucine
CsA, which inhibit binding of substrates to calcineurin zipper, a putative SH3 binding site, and three putative
(Liu et al., 1991). As shown in Figure 1B, the interaction nuclear localization sequences in Cabin 1 (Figure 2A).
between one of the clones and the mutant calcineurin In addition, Cabin 1 contains several PEST sequences
bait can be inhibited by FK506 and CsA in a dose-depen- that have been proposed to target a wide variety of
dent manner. The remaining five clones exhibited similar cellular proteins for degradation, including nuclear pro-
sensitivity to FK506 and CsA (data not shown). FK506
tein kinase C, IkBa, Fos, p53, and G1 cyclins (Rech-
was found to be over 10-fold more potent than CsA, in
steiner and Rogers, 1996) (Figure 2A). There are a num-
agreement with the relative potencies of these drugs in
ber of consensus phosphorylation sites for variousT cells (Kino et al.,1987). To further assess the specificity
kinases, including PKA, PKC, and MAP kinases (dataof the interaction, the two-hybrid assay was performed
not shown). Immunoprecipitation of Cabin 1 from frac-in the yeast strain SMY4 that lacks FKBP12 (Cardenas
tionated cell lysates followed by Western blot usinget al., 1994). In SMY4, the interaction became resistant
polyclonal anti±Cabin 1 antibodies confirmed that Cabinto FK506 while remaining sensitive to CsA, indicating
1 is a nuclear protein (Figure 2B). Cabin 1 remains inthat the sensitivity to FK506 is mediated by FKBP12 and
the nucleus upon treatment of Jurkat T cells with PMAis specific for calcineurin (Figure 1C). Sequence analysis
and ionomycin (data not shown). Northern analysis indi-revealed that four of the six clones encode overlapping
cated that Cabin 1 is widely expressed in a variety ofcDNAs of the same gene (Figure 1D); the corresponding
calcineurin binding protein was named Cabin 1. tissues, including the spleen and leukocytes (Figure 2C).
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Figure 3. Cabin 1 Specifically Interacts with
Wild-Type and Mutant Calcineurin in Jurkat
T Cells in a PMA- and Ionomycin-Dependent
Fashion
(A) Interaction between Cabin 1-14 and full-
length wild-type or H160N calcineurin b2 in
Jurkat T cells can be detected by a mamma-
lian two-hybrid assay.
(B) The interaction between Cabin 1-14 and
full-length calcineurin b2(H160N) is sensitive
to FK506, and the inhibition by FK506 is an-
tagonized by an excess of rapamycin.
(C) The interaction between Cabin 1-14 and
full-length calcineurin b2(H160N) requires
stimulation by both PMA and ionomycin in
the mammalian two-hybrid assay.
(D) The interaction between Cabin 1-14 and
full-length calcineurin b2(H160N) is sensitive
to the PKC inhibitor bisindolylmaleimide.
(E) Coimmunoprecipitation of Cabin 1-14 and
wild-type calcineurin b2 is dependenton both
PKC and calcium stimulation.
Interaction between Cabin 1 and Calcineurin inhibitory effect of FK506 in a dose-dependent manner,
indicating that the interaction between Cabin 1 and cal-Is Dependent on Both PKC
and Calcium Signals cineurin is highly specific (Figure 3B).
In the mammalian two-hybrid system, the interactionTo verify the interaction between Cabin 1 and calcineurin
in T cells, we established a mammalian two-hybrid sys- between full-length calcineurin and Cabin 1-14 requires
ionomycin, which is consistent with the activation oftem in Jurkat T cells by fusing calcineurin with the Gal4
DNA binding domain and Cabin 1-14 with the VP16 acti- full-length calcineurin by calcium and calmodulin. Unex-
pectedly, this interaction also requires PMA (Figure 3C).vation domain (Hsu et al., 1994). One advantage of this
system is that it allows for the use of various forms of Since PMA is known to activate PKC, we examined the
effect of a PKC-specific inhibitor, bisindolylmaleimidefull-length calcineurin that can be activated by calcium
signal. When stimulated with PMA and ionomycin, the (Toullec et al., 1991), on the PMA/ionomycin-stimulated
interaction between Cabin 1-14 and calcineurin. Bisin-full-length calcineurin b2(H160N) mutant showed strong
interaction with Cabin 1-14 (Figure 3A). While the wild- dolylmaleimide inhibited the interaction between cal-
cineurin and Cabin 1-14 in a dose-dependent manner,type calcineurin also interacts with Cabin 1-14, the inter-
action is several-fold weaker than that for the mutant suggesting that the requirement for PMA is mediated
through PKC activation (Figure 3D). In addition to theenzyme. The alteration of the active site structure in the
mutant appeared to have caused an increase in affinity mammalian two-hybrid system, the interaction of Cabin
1-14 and the wild-type full-length calcineurin was alsoof calcineurin for Cabin 1. Similar to the observation
made in the yeast two-hybrid assay (Figure 1B), the confirmed by coimmunoprecipitation (Figure 3E). In
agreement with the observations made in the mamma-interaction between the full-length calcineurin b2(H160N)
mutant and Cabin 1-14 is sensitive to FK506 (Figure 3B) lian two-hybrid system, Cabin 1-14 and HA-tagged cal-
cineurin (HACN) coprecipitate only upon stimulation ofand CsA (data not shown). Addition of rapamycin, an
immunosuppressant that binds FKBP12 but does not Jurkat T cells with both PMA and ionomycin (Figure 3E).
Thus, Cabin 1 interacts with calcineurin in T cells in ainhibit TCR-mediated signaling or calcineurin (Sehgal et
al., 1975; Bierer et al., 1990; Liu et al., 1991), reverts the calcium- and PKC-dependent manner.
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affect the phosphorylation state of Cabin 1-14, sug-
gesting that calcium±calcineurin signaling does not
dephosphorylate Cabin 1-14. Consistent with those ob-
servations, immunoprecipitated Cabin 1-14 is not de-
phosphorylated by recombinant calcineurin invitro (data
not shown). These results also suggest that the depen-
dence of calcineurin±Cabin 1 interaction on PKC is likely
mediated by the PKC-induced hyperphosphorylation of
Cabin 1.
Expression of Cabin 1 or Its C-Terminal Fragments
Blocks IL-2 Promoter Activation in Response
to PMA and Ionomycin
Given that Cabin 1 binds to calcineurin in T cells, we
determined whether expression of Cabin 1 or the C-ter-
minal fragment Cabin 1-14 affects calcineurin signaling
Figure 4. Activationof PKC Induces Hyperphosphorylation of Cabin upon T cell activation. Thus, Cabin 1-14 or the empty
1-14 vector were cotransfected into Jurkat T cells with a
(A) 32P labeling of Cabin 1-14 in the presence or absence of PMA luciferase reporter gene under the control of the IL-2
and ionomycin in Jurkat T cells.
promoter. Upon treatment with PMA and ionomycin, the(B) Western blot analysis of transfected Cabin 1-14 in the presence
IL-2 reporter gene is activated (Figure 5A). This activa-or absence of PMA and ionomycin.
tion is inhibited by FK506 but is unaffected by cotrans-
fection of theempty vector. Coexpression of Cabin 1-14,
however, potently inhibited the activation of the IL-2PKC Activation Leads to Hyperphosphorylation
reporter gene (Figure 5A). Similar to Cabin 1-14, the full-of Cabin 1
length Cabin 1 is also capable of inhibiting the IL-2The dual requirement of Cabin 1±calcineurin interaction
reporter gene activation in a dose-dependent manner,for calcium and PKC signals raised the question of
albeit with lower potency, suggesting that inhibition ofwhether PKC modulates this interaction by acting on
calcineurin signaling is an intrinsic activity of Cabin 1calcineurin or Cabin 1. Calcineurin is not known to be
(Figure 5A). Furthermore, as Cabin 1 is localized in thesubject to regulation by phosphorylation. The presence
nucleus (Figure 2C), the inhibitory effect of full-lengthof multiple putative kinase phosphorylation sites in
Cabin 1 on the IL-2 reporter gene also implicates thatCabin 1 suggested that Cabin 1 may be subject to PKC-
the presence of activated calcineurin in the nucleus isstimulated phosphorylation. To test this possibility and
required for IL-2 reporter gene activation in responseto determine whether the phosphorylation state of Cabin
to PMA and ionomycin. To further identify the specific1 is regulated during T cell activation, we labeled Jurkat
elements in the IL-2 promoter that are sensitive to theT cells transfected with an expression plasmid for Cabin
inhibition by Cabin 1-14, we tested reporter genes under1-14 with 32P-inorganic phosphate in the presence of
the control of multimerized AP-1, ARRE (Oct1/AP-1),PMA, ionomycin, or both. As shown in Figure 4A, Cabin
NF-AT, and NF-kB binding sites derived from the IL-21-14 is phosphorylated in unstimulated Jurkat T cells.
promoter (Figure 5B). All four reporter genes are inhib-Treatment with PMA leads to hyperphosphorylation of
ited by coexpression of Cabin 1-14, suggesting that theCabin 1-14, as evidenced by a higher level of 32P incor-
inhibitory effect of Cabin 1-14 may result from inhibitionporation and a shift in gel mobility. In contrast, the ex-
of calcineurin since these reporters are known to bepression level of Cabin 1-14 was only slightly affected
by PMA (Figure 4B). Treatment with ionomycin did not sensitive to FK506 and CsA.
Figure 5. Dominant Inhibitory Effect of Over-
expression of Cabin 1-14 on the Transcrip-
tional Activation of Different Calcineurin-
Responsive Elements in the Interleukin-2
Promoter and on the Dephosphorylation of
NF-AT in Response to PMA/Ionomycin Stim-
ulation
(A) Both Cabin 1-14 and Cabin 1 inhibit the
activation of IL-2/Luc reporter gene.
(B) Cabin 1-14 inhibits the activation of AP1/
Luc, ARRE/Luc, NF-AT/Luc, and NF-kB/Luc
reporter genes.
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for regulating the function of calcineurin after its translo-
cation into the nucleus. This isconsistent with our obser-
vations that Cabin 1 is specific for the activated form of
calcineurin. The fact that nuclearly localized full-length
Cabin 1 is capable of blocking calcineurin-mediated IL-2
reporter gene activation (Figure 5A) further implicates a
role for calcineurin in the nucleus during TCR signaling.
The interaction between Cabin 1 and calcineurin re-
quires both calcium and PKC signals as demonstrated
by the mammalian two-hybrid system and coimmuno-
Figure 6. Dephosphorylation of DNF-AT1 in Response to Iono- precipitation of the two proteins. The calcium signal is
mycin/PMA Treatment Is Inhibited by Cabin 1-14 required for activation of calcineurin, suggesting that
Jurkat T cells were transfected with various plasmids and allowed Cabin 1 only interacts with activated calcineurin. Activa-
to recover for 48 hr. Cells were then stimulated with PMA, ionomycin, tion of PKC leads to hyperphosphorylation of Cabin 1
or both for 1 hr. Whole-cell lysates were prepared, subjected to 8%
that appears to be required for its high-affinity interac-SDS-PAGE, transferred to nitrocellulose and probed with anti-HA
tion with calcineurin. We have not shown that calcineurinepitope monoclonal antibody.
and Cabin 1 interact upon TCR-induced phosphoryla-
tion of Cabin 1 using endogenous proteins due, in large
part, to the low levels of Cabin 1 and calcineurin ex-
Cabin 1-14 Inhibits Dephosphorylation of NF-AT
pressed in T cells. It also remains to be determined
by Calcineurin In Vivo
whether the PKC-dependent hyperphosphorylation of
To determine if the inhibition of IL-2 promoter by Cabin
Cabin1 isdirect or indirect. Our preliminary datasuggest
1-14 is mediated through the inhibition of calcineurin
that the hyperphosphorylation of Cabin 1 mediated by
phosphatase activity in vivo, we examined the effect of
PKC is an indirect result of theactivation of otherkinases
Cabin 1-14 on the calcineurin-mediated dephosphoryla-
by PKC (L. S., H.-D. Y., and J. O. L., unpublished data).
tion of the N-terminal fragment of NF-AT1 (DNF-AT1)
The existence of a large number of serine and threonine
upon treatment with ionomycin and PMA. Overexpres-
residues and multiple consensus phosphorylation sites
sion of Cabin 1-14 inhibited the dephosphorylation of
in Cabin 1 suggests that it may be subject to regulation
DNF-AT1 upontreatment with ionomycin in the presence
by multiple kinases. The identification of the kinases
or absence of PMA (Figure 6). It is noteworthy, however,
involved in the phosphorylation of Cabin 1 and thecorre-
that Cabin 1-14 inhibited DNF-AT1 dephosphorylation
sponding phosphorylation sites mediating its interaction
to a larger extent in the presence of PMA than in its
with calcineurin will be important for a full understanding
absence (Figure 6, lane 8 versus lane 10). These obser-
of the cross-talk between calcineurin and kinases during
vations are consistent with the PKC-dependence of the
T cell activation.
mammalian two-hybrid interaction between Cabin 1-14
In contrast to the mammalian cells, the interaction
and calcineurin (Figure 3D) and suggest that normally
between Cabin 1 and calcineurin in yeast is not depen-
phosphorylated Cabin 1-14 can interact with calcineurin
dent on PKC. Although whether Cabin 1 is phosphory-
with low affinity, and hyperphosphorylation of Cabin
lated in yeast is not known, it is possible that yeast
1-14 upon PKC activation leads to higher affinity for
contains kinases that have overlapping specificity as
calcineurin. They also support the notion that hyper-
the mammalian kinases that phosphorylate Cabin 1
phosphorylated Cabin 1-14 binds to, and inhibits the
given that calcineurin is also present in yeast. It is also
protein phosphatase activity of, calcineurin in vivo.
possible that the high level of overexpressed Cabin 1
C-terminal fragments may compensate for their low af-
Discussion finity in the absence of phosphorylation, rendering their
interactions with the calcineurin bait strong enough to
We have identified a novel calcineurin binding protein, give sufficient reporter gene activity.
Cabin 1, that is capable of binding to and inhibiting the Two alternative models can account for the function
phosphatase activity of calcineurin. The interaction be- of Cabin 1 during T cell activation. A phosphoprotein
tween Cabin 1 and calcineurin was confirmed both in a pseudosubstrate inhibitor, PP-1I, is known for another
mammalian two-hybrid system and by coimmunopre- serine/threonine phosphatase, PP-1, that belongs to the
cipitation. Overexpression of Cabin 1 or its C-terminal same superfamily of enzymes as calcineurin (Aitken et
calcineurin-binding fragments inhibits calcineurin-medi- al., 1982). PP-1I does not bind to PP-1 unless it is phos-
ated IL-2 reporter gene activation and dephosphoryla- phorylated on a threonine residue. Like Cabin 1, PP-1I
tion of NF-AT, suggesting that Cabin 1 may serve as also contains PEST sequences (Rechsteiner and Rog-
a negative regulator of TCR signaling via inhibition of ers, 1996). It ispossible that hyperphosphorylated Cabin
calcineurin. 1 binds to and inhibits the phosphatase activity of cal-
We showed that Cabin 1 is a nuclear protein. But cineurin in a manner analogous to that of PP-1I, serving
calcineurin is known as a cytosolic enzyme, raising the as an endogenous inhibitor for calcineurin. Alternatively,
question of whether Cabin 1 can form a physiologically Cabin 1 may serve as a nuclear anchoring protein for
relevant complex with calcineurin. Recently, it was calcineurin during T cell activation. This role is prece-
shown that calcineurin migrates into the nucleus via a dented by the A kinase anchoring protein (AKAP79) that
complex with NF-AT upon T cell activation (Shibasaki serves as a scaffold protein to anchor calcineurin, PKA,
and PKC to the same subcellular locations in neuronalet al., 1996). It is possible that Cabin 1 is responsible
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Nuclear Localization of Endogenous Cabin 1cells (Coghlan et al., 1995; Klauck et al., 1996). Similar
Nuclear extract was prepared from Jurkat cells as previously de-to Cabin 1, the calcineurin binding domain of AKAP79
scribed with slight modifications (Dignam et al., 1983). Exponentiallycan also inhibit the phosphatase activity of calcineurin.
growing Jurkat T cells were harvested and Dounce-homogenized
Given that Cabin 1 contains multiple structural motifs in a homogenization buffer (20 mM HEPES [pH 7.9], 1.5 mM MgCl2,
in addition to the calcineurin binding domain, it has 10 mM KCl, 0.5 mM EDTA, and 1 mM PMSF). Nuclei were precipi-
tated by centrifugation at 1,000 3 g for 10 min (the supernatant wasthe potential to bind simultaneously to multiple proteins
taken as the cytosolic fraction), washed twice, and lysed in a lysisalong with calcineurin. The fact that expression of full-
buffer (20 mM HEPES [pH 7.9] 0.1 M NaCl, 1.5 mM MgCl2, 10 mMlength Cabin 1 inhibits IL-2 reporter gene activation in
KCl, 0.5 mM EDTA, 1 mM PMSF, 1% Triton X-100, and 0.5% NP-response to PMA and ionomycin is more consistent with
40). Immunoprecipitation was carried out using both nuclear and
the first model in which Cabin 1 plays a negative regula- cytosolic fractions with anti-Cabin 1 polyclonal antibodies. This is
tory role in calcineurin signaling (Figure 5A). followed by immunoblotting with anti-Cabin 1 antibodies or a control
serum.The TCR signaling pathway is known to be down-
regulated in the course of T cell activation (Gardner,
Northern Blot Analysis1989). Activation of PKC has been previously shown
A 4 kb fragment (EcoRI, BamHI) from the 59 region of mouse Cabinto antagonize calcium signaling (Tordai et al., 1989).
1 cDNA was labeled with [a-32P]dCTP by random priming using the
Through inhibition of calcineurin in a PKC-dependent T7 Quick-Prime Kit (Pharmacia) according to the manufacturer's
fashion, Cabin 1 may serve in an internal negative feed- instructions. Radiolabeled Cabin 1 fragment was purified through
back loop to inhibit this pathway. Thus, Cabin 1 and NucTrap Probe Purification column (Stratagene) and used to probe
a human multiple-tissue Northern blot (OriGene, Rockville, MD). Thecalcineurin are localized to the nucleus and cytosol,
membrane was hybridized at 428C for 20 hr and then washed atrespectively, in quiescent T cells. Upon T cell activation,
658C in 2 3 SSC/0.1% SDS for 1 hr followed by another wash ina subpopulation of calcineurin translocates into the nu-
0.2 3 SSC/0.1% SDS for 30 min and a final wash in 0.1 3 SSC/
cleus to maintain the transcriptional activity of NF-AT 0.1% SDS for 30 min.
and possibly other factors (Shibasaki et al., 1996). Acti-
vation of PKC and other kinases leads to the hyperphos- Coimmunoprecipitation of Cabin 1-14 and Calcineurin
Jurkat T cells transfected with pSG-HACNAb2 and pSG-Cabin 1-14phorylation of Cabin 1, converting it into a high-affinity
were stimulated with PMA, ionomycin, or both for 3 hr. The cellsinhibitor for calcineurin, thereby attenuating TCR signal-
were lysed in a lysis buffer (20 mM TrisHCl [pH 7.4], 0.1 M NaCl,ing. It is noteworthy that the calcineurin binding domain
1% Triton X-100, 0.5% NP-40, and 0.5 mM PMSF). Cell lysates thus
of Cabin 1 occupies only a small portion of the entire prepared were incubated with anti-Cabin 1 polyclonal antibodies
protein. The presence of a leucine zipper motif, an SH3 and protein A/G agarose (Santa Cruz) for 2 hr, washed with lysis
binding site, and a number of putative phosphorylation buffer, and boiled in SDS sample buffer. The samples were sub-
jected to 10% SDS-PAGE, transferred to nitrocellulose that wassites in Cabin1 suggests that it is likely to bea multifunc-
probed with anti-HA monoclonal antibodies, and developed withtional protein, capable of mediating additional signaling
ECL reagents (Amersham).connections and playing other roles in T lymphocytes.
Mammalian Two-Hybrid Assays for Interaction
between Calcineurin and Cabin 1Experimental Procedures
The fusion plasmids for mammalian two-hybrid assays were con-
structed as follows. The cDNAs of calcineurinAb2 wild-type andYeast Two-Hybrid Screen
H160N mutant were fused to the GAL4 DB in the pM vector (Clon-Cabin 1 cDNA fragments were isolated by a yeast two-hybrid screen
tech) [pMCNb2 and pMCNb2(H160N)], and the cDNA of Cabin 1-14of a mouse T cell cDNA library (obtained from Dr. Steve Elledge). The
was fused to the VP16 AD in the pVP16 vector (pVPCabin1-bait plasmid was constructed by the insertion of a cDNA fragment
14). Jurkat T cells were transfected with 5 mg of pMCNb2 orencoding the first 410 amino acids of CNb2 with a mutation (H160N)
pMCNAb2(H160N), 5 mg of pVPCabin1-14, 1 mg of pCMV-bGal, andinto the BamHI and Sal1 sites in pAS2 to give pAS-CNb2m. Subse-
2 mg of pG5Luc, a luciferase reporter plasmid containing GAL4quently, an expression cassette of CNB under the control of yeast
promoter, by electroporation (960 mF, 250 V). After 48 hr, cells wereADH promoter was inserted into a blunted SacI site of pAS-CNb2m.
stimulated with 10 nM PMA and 1 mM ionomycin, either alone or inThe calcineurin bait plasmid was transformed into the yeast strain
combination, for 6 hr before luciferase activity was measured forY190, followed by transformation with the mouse T cell cDNA library
each sample. Where applied, FK506, rapamycin, cyclosporin A, and(Elledge et al., 1991). The transformed yeast were selected on drop-
bisindolylmaleimide were added to Jurkat cells 30 min prior to theout plates (His2, Leu2, Trp2) with 50 mM 3-amino-1,2,4-triazole.
stimulation.Positive colonies were picked 5 days after plating and streaked on
X-Gal (Leu2, Trp2) plates. Colonies that turned blue overnight were
Reporter Gene Assaysfurther subjected to liquid b-gal assay to confirm the lacZ reporter
The luciferase reporter gene assay reagents were obtained fromgene expression. DNA from those colonies were retrieved and se-
Promega, and the assay was performed per manufacturer's instruc-quenced.
tions. The transient transfection was performed using electropora-
tion. Jurkat cells (1 3 107) were harvested, washed once in RPMI
medium, and mixed with 2 mg of luciferase reporter plasmid andCloning of Cabin 1 cDNA
0±5 mg of expression plasmid for Cabin 1-14 in 300 ml of RPMI inThe longest mouse Cabin 1 cDNA fragment obtained from the yeast
a sterile cuvette. An electric pulse (250 V, 960 mF) was applied (Bio-two-hybrid screen was used to search the EST database. Two over-
Rad Gene Pulser II). Where appropriate, the transfection efficiencylapping cDNA fragments encoding a human Cabin 1 were identified.
was measured by cotransfecting 2 mg of CMV-driven b-galactosi-They were obtained from Dr. Takahiro Nagase, Kazusa DNA Re-
dase expression vector and measuring enzymatic b-galactosidasesearch Institute, and Genome System Inc., respectively. Using a
activity (Ausubel et al., 1994).primer derived from these clones, a RACE PCR was performed with
a human kidney cDNA library to obtain a 1.5 kb cDNA fragment
corresponding to the remaining 59 region of Cabin 1 cDNA. The Dephosphorylation of NF-AT by Calcineurin In Vivo
Jurkat T cells were transfected with expression vectors for Cabinsequences of these clones were confirmed, and the longest ORF
encodes 2220 amino acids with a consensus Kozak initiation se- 1-14 (pSGCabin 1-14) and for HA-epitope-tagged truncated NF-
AT1(1±460) fused to green fluorescent protein [pSG-DNF-AT1quence preceded by stop codons.
Immunity
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(1±460)] by electroporation as described above. After 48 hr, cells Escherichia coli mutations. Proc. Natl. Acad. Sci. USA 88, 1731±
1735.were treated with PMA and ionomycin, either alone or in combina-
tion, for another 1 hr. Whole-cell lysates were prepared and sub- Emmel, E.A., Verweij, C.L., Durand, D.B., Higgins, K.M., Lacy, E., and
jected to 8% SDS±polyacrylamide gel electrophoresis, transferred Crabtree, G.R. (1989). Cyclosporin A specifically inhibits function of
to nitrocellulose membrane (Schleicher and Schuell, NH), probed nuclear proteins involved in T cell activation. Science 246, 1617±
with anti-HA epitope monoclonal antibody, and developed with ECL 1620.
reagents (Amersham). Fields, S., and Song, O.-K. (1989). A novel genetic system to detect
protein-protein interactions. Nature 340, 245±246.
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